This on-line discussion focuses on understanding the current role of immunotherapy in treating cancer, explores promising new developments in the field and discusses immunotherapy’s potential for treating FLC. In the recorded event, Mark Furth, FCF’s Scientific Director, moderates a conversation with Elizabeth Jaffee, MD, Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and Paul Thomas, PhD, a member of the faculty of St. Jude Children’s Research Hospital.
The discussion can be viewed below: